N. Friedmann - Concepedia

Author

N. Friedmann

Cassava Sciences (United States)

Also Known As

N Friedmann, N. FRIEDMANN, N. Friedmann, Nadav Friedmann, Nadav Friedmann, PhD, MD

Publications

866

Citations

H-Index

Concepts

All Affiliations

Cassava Sciences (United States)Institute for Atherosclerosis Research Albert Einstein College of Medicine Ortho Clinical Diagnostics (United States)

About

N. Friedmann is an author at Cassava Sciences (United States) specializing in medicine, pharmacology, and pain management.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	517
2	Health Sciences	3	3	289
3	Education	1	1	14
4	Anesthesia	1	1	116
5	Biochemistry	1	1	37

N. Friedmann

Publications

832

Citations

H-Index

Page 1

	Year	Citations
Oxytrex Minimizes Physical Dependence While Providing Effective Analgesia: A Randomized Controlled Trial in Low Back Pain Lynn R. Webster, P. Butera, Lauren V. Moran, Journal of Pain Pain TherapyHealth SciencesPain MedicineEffective AnalgesiaPostoperative Pain Management	2006	136
Inhibition of Endotoxin-Induced Cytokine Release and Neutrophil Activation in Humans by Use of Recombinant Bactericidal/Permeability-Increasing Protein M. A. M. Von Der Möhlen, A N Kimmings, Nancy Wedel, The Journal of Infectious Diseases Neutrophil ActivationEndotoxin LevelsImmunologyRecombinant Endotoxin-binding ProteinCell Death	1995	123
Adding Ultralow-Dose Naltrexone to Oxycodone Enhances and Prolongs Analgesia: A Randomized, Controlled Trial of Oxytrex Vishala Chindalore, Richard Craven, Kevin Yu, Journal of Pain Pain MedicinePharmacotherapyPain ManagementUltralow-dose NaltrexoneProlongs Analgesia	2005	116
Evaluation of a CD5-specific immunotoxin for treatment of acute graft- versus-host disease after allogeneic marrow transplantation PJ Martin, BJ Nelson, FR Appelbaum, Blood	1996	90
Inhibition of endotoxin-induced activation of the coagulation and fibrinolytic pathways using a recombinant endotoxin-binding protein (rBPI23) MA von der Mohlen, SJ van Deventer, Marcel Levi, Blood	1995	46
Safety and Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients with Metastatic Melanoma Marc Klein, Michal Lotem, Tamar Peretz, Journal of Skin Cancer Melanoma MetastasesMedicineMelanomaMetastatic MelanomaImmune Checkpoint Inhibitor	2013	43
PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients H.-Y. Wang, Zhen‐Ming Pei, K.-C. Lee, The Journal of Prevention of Alzheimer s Disease	2020	42
Bioavailability of Valproic Acid Under Fasting/ Nonfasting Regimens Alexander Chun, Daniël J. Hoffman, N. Friedmann, The Journal of Clinical Pharmacology Pharmaceutical ScienceValproic AcidBiochemistryMedicinePhysiology	1980	37
A PHASE I SAFETY AND PHARMACOKINETIC STUDY OF A RECOMBINANT AMINO TERMINAL FRAGMENT OF BACTERICIDAL/ PERMEABILITY-INCREASING PROTEIN IN HEALTHY MALE VOLUNTEERS Robert J. Bauer, Mark White, Nancy Wedel, Shock	1996	34
Efficacy and safety of an extended-release oxycodone (Remoxy®) formulation in patients with moderate to severe osteoarthritic pain N. Friedmann, BS Vicki Klutzaritz, Lynn R. Webster Journal of Opioid Management	2011	33

Page 1